Poly Medicure's Q2 FY 2025-26 Quarterly Results

Result Summary

• Poly Medicure Ltd reported a 7.4% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 7.1%.
• Its expenses for the quarter were up by 10.5% QoQ and 8.6% YoY.
• The net profit decreased 1.4% QoQ and increased 5.0% YoY.
• The earnings per share (EPS) of Poly Medicure Ltd stood at 9.06 during Q2 FY 2025-26.

Financial Statments for Q2 FY 2025-26

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

## Company Overview
Poly Medicure Ltd is a prominent player in the healthcare sector, specializing in the manufacture and sale of medical devices. The company is known for its extensive range of products, including intravenous (IV) cannulae, infusion sets, blood bags, and other hospital consumables. Poly Medicure operates within the broader medical device industry, which is characterized by high demand due to the growing emphasis on healthcare infrastructure and medical advancements. As of the latest data, there are no specific recent major developments provided for the company.

## Revenue
In Q2FY26, Poly Medicure Ltd reported a total income of ₹477.83 crores, reflecting a quarter-over-quarter (QoQ) increase of 7.4% from ₹444.90 crores in Q1FY26 and a year-over-year (YoY) increase of 7.1% from ₹446.11 crores in Q2FY25. This growth in total income over both periods suggests a positive trend in revenue generation. The company's ability to generate higher income compared to the prior periods is shown in the provided data.

## Profitability
The company's profit before tax for Q2FY26 stood at ₹120.73 crores, marking a slight decrease of 0.7% QoQ from ₹121.62 crores in Q1FY26 but an increase of 2.3% YoY from ₹117.98 crores in Q2FY25. The tax expenses remained relatively stable, with a marginal increase of 0.1% QoQ but a decrease of 2.1% YoY. Consequently, the profit after tax amounted to ₹91.80 crores in Q2FY26, representing a decline of 1.4% QoQ from ₹93.08 crores in Q1FY26, yet a growth of 5.0% YoY from ₹87.45 crores in Q2FY25. Earnings per share (EPS) for the quarter was ₹9.06, showing slight changes from previous quarters.

## Operating Metrics
Total expenses for Q2FY26 were ₹357.10 crores, which reflects a 10.5% increase QoQ from ₹323.28 crores in Q1FY26 and an 8.6% increase YoY from ₹328.88 crores in Q2FY25. The upward trend in expenses might be associated with operational activities or cost adjustments. The earnings per share (EPS) in Q2FY26 were ₹9.06, a slight decrease of 1.2% QoQ from ₹9.17 in Q1FY26 and a minor increase of 0.6% YoY from ₹9.01 in Q2FY25. These metrics provide an overview of the company's operational efficiency and cost management strategies during the period under review.